Pamela P. Palmer - Aug 24, 2023 Form 4 Insider Report for ACELRX PHARMACEUTICALS INC (ACRX)

Role
Chief Medical Officer, Director
Signature
/s/ Martha Adler. Attorney-In-Fact
Stock symbol
ACRX
Transactions as of
Aug 24, 2023
Transactions value $
-$19,236
Form type
4
Date filed
8/25/2023, 04:45 PM
Previous filing
Mar 6, 2023
Next filing
Feb 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRX Common Stock Sale -$11.1K -9.51K -19.94% $1.17 38.2K Aug 24, 2023 Direct F1, F2
transaction ACRX Common Stock Sale -$8.1K -7.44K -19.48% $1.09 30.8K Aug 25, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.17 to $1.19 on August 24, 2023. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares sold at each separate price.
F2 Balance includes non-reportable acquisition of 4,394 shares of Common Stock through the Company's Employee Stock Purchase Plan on February 28, 2023.